Document Detail


Stem cells in cardiac repair.
MedLine Citation:
PMID:  16483849     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Advances in the treatment of acute myocardial infarction have led to increased survival but also an increase in those suffering from heart failure. The concept of adult progenitor cell therapy has grown from observations that cardiac function improves after injection of bone marrow-derived cells into infarcted regions in animal models. The mechanism of action is unclear and is probably multifactorial. Different subpopulations of autologous cells have been utilised in humans with acute myocardial infarction and heart failure, as well different routes of delivery. These small Phase I clinical trials suggest that this approach is safe and leads to clinical improvement, and larger scale randomised control studies are underway. We believe that cell therapy heralds a revolutionary new era in the treatment of disease.
Authors:
Nicholas F Grigoropoulos; Anthony Mathur
Related Documents :
12086469 - Experimental studies on the spatiotemporal expression of wt1 and raldh2 in the embryoni...
12064589 - Increased co-localization of connexin43 and zo-1 in dissociated adult myocytes.
12553709 - Histochemical and ultrastructural characterisation of an arrhythmogenic substrate in is...
17562779 - Therapeutic angiogenesis with bone marrow--derived stem cells.
15861009 - Matrix modulation and heart failure: new concepts question old beliefs.
17495229 - Effect of cell-based intercellular delivery of transcription factor gata4 on ischemic c...
6980329 - Isolated coronary artery bypass grafting in patients seventy years of age and older: ea...
20513729 - Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.
14569239 - Perioperative and long-term prognostic value of dipyridamole tc-99m sestamibi myocardia...
Publication Detail:
Type:  Journal Article; Review     Date:  2006-02-17
Journal Detail:
Title:  Current opinion in pharmacology     Volume:  6     ISSN:  1471-4892     ISO Abbreviation:  Curr Opin Pharmacol     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-03-13     Completed Date:  2006-08-03     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100966133     Medline TA:  Curr Opin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  169-75     Citation Subset:  IM    
Affiliation:
Cardiac Research Department, The London Chest Hospital, Bonner Road, London E2 9JX, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bone Marrow Transplantation*
Clinical Trials, Phase I as Topic
Disease Models, Animal
Heart Failure / therapy*
Humans
Myocardial Infarction / therapy*
Neovascularization, Physiologic
Stem Cell Transplantation*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.
Next Document:  NADPH oxidase and heart failure.